Yu-Cheng Lee - Search Results

Year	Number of Results
2008	1
2010	2
2012	1
2013	6
2014	2
2015	1
2016	5
2017	2
2018	1
2019	2
2020	1
2021	6
2022	6
2023	4
2024	2

1

The dynamic roles of the bladder tumour microenvironment.

Lee YC, Lam HM, Rosser C, Theodorescu D, Parks WC, Chan KS. Lee YC, et al. Nat Rev Urol. 2022 Sep;19(9):515-533. doi: 10.1038/s41585-022-00608-y. Epub 2022 Jun 28. Nat Rev Urol. 2022. PMID: 35764795 Free PMC article. Review.

2

Landscape of Pin1 in the cell cycle.

Lin CH, Li HY, Lee YC, Calkins MJ, Lee KH, Yang CN, Lu PJ. Lin CH, et al. Among authors: lee yc. Exp Biol Med (Maywood). 2015 Mar;240(3):403-8. doi: 10.1177/1535370215570829. Epub 2015 Feb 7. Exp Biol Med (Maywood). 2015. PMID: 25662955 Free PMC article. Review.

3

Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.

You S, Kim M, Hoi XP, Lee YC, Wang L, Spetzler D, Abraham J, Magee D, Jain P, Galsky MD, Chan KS, Theodorescu D. You S, et al. Among authors: lee yc. J Natl Cancer Inst. 2022 Oct 6;114(10):1380-1391. doi: 10.1093/jnci/djac140. J Natl Cancer Inst. 2022. PMID: 35918812 Free PMC article.

4

Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17.

Chan YJ, Hsiao G, Wan WN, Yang TM, Tsai CH, Kang JJ, Lee YC, Fang TC, Cheng YW, Li CH. Chan YJ, et al. Among authors: lee yc. Fluids Barriers CNS. 2023 Apr 24;20(1):31. doi: 10.1186/s12987-023-00430-7. Fluids Barriers CNS. 2023. PMID: 37095509 Free PMC article.

5

Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism.

Lee YC, Chung HH. Lee YC, et al. Br J Clin Pharmacol. 2023 Mar;89(3):1222-1223. doi: 10.1111/bcp.15630. Epub 2022 Dec 27. Br J Clin Pharmacol. 2023. PMID: 36575627 Free article. No abstract available.

6

How Sensitive is Pan-TRK Immunohistochemistry for Detecting NTRK Fusions in Papillary Thyroid Carcinoma?

Hang JF, Lee YC. Hang JF, et al. Among authors: lee yc. Mod Pathol. 2023 Jul;36(7):100222. doi: 10.1016/j.modpat.2023.100222. Epub 2023 Jun 18. Mod Pathol. 2023. PMID: 37336120 No abstract available.

7

NTRK-rearranged papillary thyroid carcinoma demonstrates frequent subtle nuclear features and indeterminate cytologic diagnoses.

Lee YC, Hsu CY, Lai CR, Hang JF. Lee YC, et al. Cancer Cytopathol. 2022 Feb;130(2):136-143. doi: 10.1002/cncy.22522. Epub 2021 Oct 13. Cancer Cytopathol. 2022. PMID: 34644010 Free article.

8

RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis.

Ho SR, Lee YC, Ittmann MM, Lin FT, Chan KS, Lin WC. Ho SR, et al. Among authors: lee yc. Cancer Lett. 2021 Nov 1;520:344-360. doi: 10.1016/j.canlet.2021.08.008. Epub 2021 Aug 13. Cancer Lett. 2021. PMID: 34400221 Free PMC article.

9

Empirical research on Kano's model and customer satisfaction.

Lin FH, Tsai SB, Lee YC, Hsiao CF, Zhou J, Wang J, Shang Z. Lin FH, et al. Among authors: lee yc. PLoS One. 2017 Sep 5;12(9):e0183888. doi: 10.1371/journal.pone.0183888. eCollection 2017. PLoS One. 2017. PMID: 28873418 Free PMC article.

10

Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy.

Rodriguez-Brenes IA, Kurtova AV, Lin C, Lee YC, Xiao J, Mims M, Chan KS, Wodarz D. Rodriguez-Brenes IA, et al. Among authors: lee yc. Cancer Res. 2017 May 1;77(9):2231-2241. doi: 10.1158/0008-5472.CAN-16-2434. Epub 2017 Feb 24. Cancer Res. 2017. PMID: 28235762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year